PATENT CLAIM ANALYSIS

Application Number: 15749584
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "230200"]

Abstract:
Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV.

Claim (Index 25):
The composition of  claim 24  further comprising at least one other agent used for treatment of HIV infection selected from nucleoside HIV reverse transcriptase inhibitors, non-nucleoside HIV reverse transcriptase inhibitors, HIV protease inhibitors, HIV fusion inhibitors, HIV attachment inhibitors, CCR5 inhibitors, CXCR4 inhibitors, HIV budding or maturation inhibitors, and HIV integrase inhibitors, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.23333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15749133', '15749189', '15579977', '14770702', '16094536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7871315424668475
- 35 USC 102 Novelty (BERT): 0.5781997817446393
- Combined Prediction Score: 0.7662383663946267
- Mean Citation Score: 433.226472
- Max Citation Score: 481.00058
- Similarity Product: 393.25593076257934

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test